The burden of serogroup B meningococcal disease

The Lancet Neurology

Volumn 11, Issue 9, 2012, Pages 743-745

  Van de Beek, Diederik ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

AMPUTATION; BACTEREMIA; BACTERIAL VIRULENCE; COGNITION; COGNITIVE DEFECT; DISABILITY; EXECUTIVE FUNCTION; HUMAN; IMMUNE RESPONSE; LETTER; MEMORY DISORDER; MENINGOCOCCEMIA; MENINGOCOCCOSIS; MENTAL DISEASE; MENTAL HEALTH; NEISSERIA MENINGITIDIS; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVOR; VACCINATION; VIRUS TYPING;

FEMALE; HUMANS; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS;

EID: 84865131962     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70184-9     Document Type: Letter

References (11)

1. Stephens DS, Greenwood B, Brandtzaeg P Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007, 369:2196-2210.
2. McIntyre PB, O'Brien KL, Greenwood B, van de Beek D Impact of vaccines on bacterial meningitis worldwide. Lancet 2012, (in press).
3. Brouwer MC, Read RC, van de Beek D Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:262-274.
4. Viner R, Booy R, Johnson H, et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol 2012, published online Aug 3. http://dx.doi.org/10.1016/S1474-4422(12)70180-1.
5. Hoogman M, van de Beek D, Weisfelt M, de Gans J, Schmand B Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry 2007, 78:1092-1096.
6. van de Beek D, Schmand B, de Gans J, et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002, 186:1047-1052.
7. Bronner MB, Knoester H, Sol JJ, Bos AP, Heymans HS, Grootenhuis MA An explorative study on quality of life and psychological and cognitive function in pediatric survivors of septic shock. Pediatr Crit Care Med 2009, 10:636-642.
8. van Gool WA, van de Beek D, Eikelenboom P Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 2010, 375:773-775.
9. Chavan SS, Huerta PT Robbiati S, et al. Mol Med 2012; published online May 16, DOI:2119/molmed.2012.00195. http://www.ncbi.nlm.nih.gov/pubmed/22634723.
10. Gossger N, Snape MD, Yu L-M, et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 2012, 307:573-582.
11. Santolaya ME, O'Ryan ML, Valenzuela MT, et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 2012, 379:617-624.